Medicinal Products

Eribulin Accord 0,44 mg/ml otopina za injekciju

Name Eribulin Accord 0,44 mg/ml otopina za injekciju
Marketing Authorisation Number HR-H-327971497
Active Substance eribulinmesilat
Composition jedan ml otopine sadrži 0,44 mg eribulina u obliku eribulinmesilata
Pharmaceutical Form otopina za injekciju
Manufacturer Accord Healthcare Single Member S.A., Lamia, Grčka
Accord Healthcare Polska Sp. z o.o., Pabianice, Poljska
Marketing Authorisation Holder Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska
Marketing Authorisation Date 08.06.2026
MA Period of Validity 08.06.2031
Classification Number UP/I-530-09/24-01/05
Registration Number 381-12-01/70-26-11
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product subject to restricted medical prescription
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code L01XX41
Marketing status Never marketed
SmPC download
PL download
Public Assessment Report download
Summary of risk management plan download

Packaging

Back